Back | Next |
home / stock / ktra / ktra message board
Subject | By | Source | When |
---|---|---|---|
I am going to sell today on a | retiredtech | investorshub | 12/13/2022 10:39:18 AM |
I already sold with a double from 7.20. | dinogreeves | investorshub | 12/13/2022 4:14:07 AM |
What is happening here is TOTALLY CRIMINAL with | retiredtech | investorshub | 12/12/2022 10:32:58 PM |
Agree | HJ72 | investorshub | 12/12/2022 6:17:23 PM |
Their priority IS NOT the PPS. It | retiredtech | investorshub | 12/12/2022 6:03:30 PM |
Yes theyre priority is not the PPS. | HJ72 | investorshub | 12/12/2022 4:14:09 PM |
I do not fear the dip. I | retiredtech | investorshub | 12/12/2022 4:10:37 PM |
Dont fear this little dip were holding a | HJ72 | investorshub | 12/12/2022 3:36:18 PM |
IF management lets this stock sit with NO | retiredtech | investorshub | 12/12/2022 3:19:29 PM |
Yes, we will get there regardless. I | dinogreeves | investorshub | 12/12/2022 6:44:11 AM |
FINVIZ says Target Price $150.00 | retiredtech | investorshub | 12/12/2022 6:43:11 AM |
Undeniably one of the lowest market cap biotech | dinogreeves | investorshub | 12/12/2022 4:24:32 AM |
One news will send this instantly above $20. | dinogreeves | investorshub | 12/12/2022 4:15:02 AM |
$KTRA is waiting to erupt and make a | dinogreeves | investorshub | 12/12/2022 2:23:28 AM |
znewcar1: $KTRA 14% v504K c14.80 f1,616M H15.4999 YL9.5 | znewcar1 | investorshangout | 12/10/2022 3:49:35 AM |
MM's doing literally everything they can to STOP | retiredtech | investorshub | 12/09/2022 8:46:35 PM |
I think most traders are expecting funding for | retiredtech | investorshub | 12/09/2022 6:13:45 PM |
The slow accumulation got me wondering what news | imrichbeotch | investorshub | 12/09/2022 4:25:29 PM |
Hugely bullish on this one. The pattern | dinogreeves | investorshub | 12/09/2022 5:06:54 AM |
Fantastic close. | dinogreeves | investorshub | 12/08/2022 9:27:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Kintara Therapeutics Inc Com Company Name:
KTRA Stock Symbol:
NASDAQ Market:
Kintara Therapeutics Inc Com Website:
TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.'s KVA12123 Novel anti-VISTA Checkpoint Inhibitor PR Newswire KVA12123 is a rationally targeted, anti-VISTA antibody checkpoint inhibitor to reverse VISTA immune suppression and remod...
Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones PR Newswire SAN DIEGO , July 1, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutic...